These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10436140)

  • 1. Clinical implications of elevated PAI-1 revisited: multiple arterial thrombosis in a patient with essential thrombocythemia and elevated plasminogen activator inhibitor-1 (PAI-1) levels: a case report and review of the literature.
    Senno SL; Pechet L
    J Thromb Thrombolysis; 1999 Aug; 8(2):105-12. PubMed ID: 10436140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic imbalance in essential thrombocythemia: role of platelets.
    Bazzan M; Tamponi G; Gallo E; Stella S; Schinco PC; Pannocchia A; Pileri A
    Haemostasis; 1993; 23(1):38-44. PubMed ID: 8477907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and comparative evaluation of a structurally unique PAI-1 inhibitor exhibiting oral in-vivo efficacy.
    Crandall DL; Elokdah H; Di L; Hennan JK; Gorlatova NV; Lawrence DA
    J Thromb Haemost; 2004 Aug; 2(8):1422-8. PubMed ID: 15304050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional stability of plasminogen activator inhibitor-1.
    Yasar Yildiz S; Kuru P; Toksoy Oner E; Agirbasli M
    ScientificWorldJournal; 2014; 2014():858293. PubMed ID: 25386620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of peripheral arterial thrombolysis due to elevated plasminogen activator inhibitor type 1.
    Nicholls SC; Hoffer EK; Chandler WL
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):729-33. PubMed ID: 14614351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High concentrations of active plasminogen activator inhibitor-1 in porcine coronary artery thrombi.
    Fay WP; Murphy JG; Owen WG
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1277-84. PubMed ID: 8857925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis.
    Cancelas JA; García-Avello A; García-Frade LJ
    Thromb Res; 1994 Sep; 75(5):513-20. PubMed ID: 7992252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator levels are influenced by location and varicosity in greater saphenous vein.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC; Yao JS
    J Vasc Surg; 1996 Nov; 24(5):719-24. PubMed ID: 8918314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The plasma levels of prostanoids and plasminogen activator inhibitor-1 in primary and secondary thrombocytosis.
    Birdane A; Haznedaroğlu IC; Bavbek N; Koşar A; Büyükaşik Y; Ozcebe O; Dündar SV; Kirazli S
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):197-201. PubMed ID: 15821826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PAI-1: a new anti-thrombotic approach.
    Wu Q; Zhao Z
    Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):27-42. PubMed ID: 12769655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.
    Jänicke F; Prechtl A; Thomssen C; Harbeck N; Meisner C; Untch M; Sweep CG; Selbmann HK; Graeff H; Schmitt M;
    J Natl Cancer Inst; 2001 Jun; 93(12):913-20. PubMed ID: 11416112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease.
    Wiman B
    Thromb Haemost; 1995 Jul; 74(1):71-6. PubMed ID: 8578529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor.
    Lau HK; Teitel JM; Cheung T; Kung SK; Garvey MB
    Am J Hematol; 1993 Dec; 44(4):260-5. PubMed ID: 8237997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition.
    Pinsky DJ; Liao H; Lawson CA; Yan SF; Chen J; Carmeliet P; Loskutoff DJ; Stern DM
    J Clin Invest; 1998 Sep; 102(5):919-28. PubMed ID: 9727060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.